Sanofi (SNY)
Sanofi is a French pharmaceutical company that makes and sells medicines for patients and healthcare providers. It last closed at $46.52 on Nov 20, up 1.00% on the day.
Key Stats
Last 12 monthsNot reported for this period.
From SNY's SEC filings, latest 20-F for the period ending Dec 31, 2025 (filed Feb 17). Last 12 months adds up the four latest quarters. Figures are in EUR. Per share figures are left out because the US listing can represent a different number of shares.
Earnings
Full earnings history →Technical AnalysisPrices may be delayed
The stock is 1% above its 20 day and 7% above its 50 day average. It is 5% above its 200 day average, so the longer trend is still up. Momentum is neutral (RSI 57). The nearest support is the Pivot S1 at $46.32, and the nearest resistance the Pivot at $46.65.
| RSI (14) | 57.47 | Middle of its range | Neutral |
| MACD | 1.32 | Below its signal line | Bearish |
| Stochastic | 45.0 | Middle of its range | Neutral |
| ADX (14) | 33.5 | Trending up | |
| Williams %R | -60.7 | Oversold below −80, overbought above −20 | Neutral |
| CCI (20) | 18.9 | Oversold below −100, overbought above 100 | Neutral |
| Rate of change | −1.1% | Change over 10 sessions | Bearish |
| ATR (14) | $1.01 | Typical daily range, 2.2% of price |
| RSI (14) | 57.14 | Middle of its range | Neutral |
| MACD | 0.16 | Above its signal line | Bullish |
| Stochastic | 86.6 | Near the top of its range | Overbought |
| ADX (14) | 21.3 | Weak trend | |
| Williams %R | -24.8 | Oversold below −80, overbought above −20 | Neutral |
| CCI (20) | 133.2 | Oversold below −100, overbought above 100 | Overbought |
| Rate of change | +8.8% | Change over 10 sessions | Bullish |
| ATR (14) | $2.32 | Typical daily range, 5.0% of price |
What happened before
See how SNY did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How SNY has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2005.
Whale Options FlowPrices may be delayed
90DNo whale options trades in SNY in the last 90 days.
Dark PoolPrices may be delayed
30DSNY Institutional Ownership
Full report →- ●348 buying vs 308 selling
- ▼Shares held by funds -5.5%
- ▼Funds holding -33
- ▲Superinvestors: 3 added, 1 cut
- ●Put/call not meaningful
| Q3 2026 | This quarter | Last quarter | Change |
|---|---|---|---|
| Funds holding | 693 | 726 | −4.5% |
| In funds' top 10 | 5 | 3 | +66.7% |
| Held by funds | – | – | – |
| New / increased | 70 / 278 | 82 / 217 | +16.4% |
| Reduced / sold out | 218 / 90 | 295 / 101 | −22.2% |
| Put/call ratio | 0.29 | 0.19 | +55.0% |
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper tradingStreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SNY is in one of them and how their past SNY trades turned out.
SNY News Tone and PricePrices may be delayed
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered SNY in an article yet. Here's the latest on the wider market.
- Potential Sanofi-Insmed Deal: Analysts Split on Financial Strain Versus Pipeline Gains
- With Dupixent's Patent Clock Ticking, Sanofi Circles Insmed
- As Sanofi's Pompe drug shortage drags on, some patients struggle to access treatments
- Dual Regulatory Wins for Sanofi Bring New Oral Gaucher Therapy and Upgraded Rabies Shot
- Jacobs Scores Key Role in Sanofi's New Insulin Factory in Germany
- Q3 2026: double-digit growth in sales and business EPS
- Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in Germany
SNY Congress Trades
All congress trades →| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Alan ArmstrongR · OK | Buy | $15K – $50K | Mar 30, 2026 | Jul 21, 2026 | 113 d |
| Lisa McClainR · MI | Sell | $1K – $15K | Sep 11, 2025 | Oct 22, 2025 | 41 d |
| Lisa McClainR · MI | Buy | $1K – $15K | Aug 4, 2025 | Sep 12, 2025 | 39 d |
| Lisa McClainR · MI | Sell | $1K – $15K | Jul 22, 2025 | Aug 13, 2025 | 22 d |
| Lisa McClainR · MI | Buy | $1K – $15K | Jun 17, 2025 | Aug 13, 2025 | 57 d |
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Sanofi
Sanofi is a pharmaceutical company headquartered in Paris, France. It makes and sells pharmaceutical preparations, which are medicines used to prevent, treat or manage health conditions. Its customers include patients, doctors, hospitals and pharmacies, and it sells its products in many countries around the world.
- Headquarters
- Paris, France
- Founded
- 2004
- Website
- sanofi.com ↗









